Literature DB >> 27751848

Regorafenib: efficacy in multiple refractory sarcoma types.

John H Healey1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27751848     DOI： 10.1016/S1470-2045(16)30509-5

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN： 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  2 in total

1.  CORR Insights®: Does an Algorithmic Approach to Using Brachytherapy and External Beam Radiation Result in Good Function, Local Control Rates, and Low Morbidity in Patients With Extremity Soft Tissue Sarcoma?

Authors:  John H Healey
Journal:  Clin Orthop Relat Res       Date:  2018-03       Impact factor: 4.176

2.  Anorexia, Hypertension, Pneumothorax, and Hypothyroidism: Potential Signs of Improved Clinical Outcome Following Apatinib in Advanced Osteosarcoma.

Authors:  Lu Xie; Jie Xu; Xin Sun; Xiaodong Tang; Taiqiang Yan; Rongli Yang; Wei Guo
Journal:  Cancer Manag Res       Date:  2020-01-07       Impact factor: 3.989
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.